In the present study, MEOX2 overexpression was associated with chemoresistance in NSCLC, which was in contrast to its physiological functions in somite morphogenesis [38] and vascular endothelial growth arrest control via NFkB inhibition [39]. The gene discussed is MEOX2; the disease is non-small cell lung carcinoma.